Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My point was mostly towards the speculation that dismissing the last one had to mean buy out or the like. I think that is a far fetched conclusion to draw.
We don't know if they have retained the services of another PR firm. The lack of PR's could be an indication that they have not, but all we know is that they seemingly have let go of the one we knew they have used in the past, as NWBO does not figure on their website.
Not sure what you mean, but to me it looked like Thermo was indicating that he was expecting a buy out in the future (He didn't mention a timeline, but I sense it is not the near future). He could have been asked to help out with recommending an investment bank to them, though he didn't specifically say that. My point was that at this time, due to the severely depressed share price, I thought it more likely that we would see a deal for some indications, if we see anything at all. If for some reason the shorts will not be successful in their quest moving forward and we see a nice rally in the share price which will lead to a relisting, he could be right.
I think we will see a lot more legal shorts as we move towards the next milestones. In the past they did not have a huge need for legal shorts as they had the spoofing to cover behind when they worked their bear raids. In the future, assuming that the spoofing is off the table now, they will actually need the shares to move/cap the share price. Based on the fact that the spoofing was so successful in the past, I also think that naked shorting have been minimal as it was not needed. We might see an uptick in naked shorting as they get more desperate. I wonder if the MM's would facilitate naked shorting right now as they are likely already, or about to be, heavily scrutinized when it comes to NWBO. The guilty verdict of the JPM commodities trader is also a hugely significant plus for our law suit. I am 100% sure that news has been watched carefully in the companies that are part of the suit. I would love to be a fly on the wall at the lunch breaks of the traders overseeing the spoofing algorithms. They might not even be talking about it, but carefully watching the behavior of their co-workers to see if they can spot any signs of weakness. If one of them starts acting weird, there might be a race to become the first whistleblower.
I am not predicting anything regarding the immediate future of the Share Price, but the next few weeks should be very interesting to watch. The current various movements to expose these companies, Finra and the SEC are definitely smoldering below the surface. I might even take small positions in GTII, FNGR and CRTD, but would view those positions as lottery tickets as opposed to serious investments, mostly because of the relatively small MC's of those companies.
My investment thesis in regard to NWBO has been that there will not be a buy out. I base that on information I received in early 2020 from people with direct contacts to NWBO as a third party service provider. I am not saying it can't happen, but it is not part of my investment thesis. I do see deals for various indications on the horizon. How these deals will be structured and for how many indications, is anyone's guess. Could these deals lead to a buy out? Possibly, but I just don't see that happening prior to any other deals.
I just uploaded the webinar by Dr Linda Liau on DcVax. https://t.co/5gGSVpD9TV This version doesn't have the questions and answers section.. I am hoping to be able to upload that soon
— Al Musella (@AlMusella) December 11, 2022
I would rather not make any guesses. I don't know which indications the deal will be for, what the potential revenue for each indication is, what revenue/profit split they are talking about etc. I just know that any deal would make sure that NWBO would be adequately funded to do what they plan to do and that the milestone payments would be a very nice bonus when those are reached. I do think that the deal would significantly add to NWBO's earnings potential as it would likely be for more indications that GBM and that any partner would be able to assist with a much faster timeline for potential trials that would be asked for. I am not worried at this time to give up X% of revenues/profit is it means a much larger potential revenue base.
I think the first deal, if any, will be for limited indications, so his likely choices are not mine.
I think he just didn't want everyone to post his name all over the place at this point in order to not draw anymore attention to that person. I am sure his legal team is dissecting the situation and they will eventually post the whole thing again when confirmed that nothing in it is actionable.
We all know who that person is.
Google BMY NKTR deal and you have what I think would be best possible solution, minus the equity investment. The numbers will obviously be different, but a great framework for a pre-revenue biotech deal.
LOL. Uncle Ex!
You can't possibly believe what you post. You are allowed to look at multiple factors when analyzing the value of this new Moonshot guidance. Nothing ever happens in a vacuum.
Musella Foundation on Reddit:
"Just want to clear up the part about me. Taking down the video had nothing to do with northwest bio. It is due to harassment and legal threats from a person I can’t talk about completely unrelated to anything medical. And please don’t try to guess who as that would just cause more problems. I am working on it. Those who know me, know I never give up and eventually get what I want done.
And as to the company being quiet, I am not an insider and do not know the true reasons, but my guess is that every time they announce good news the stock goes down so why say anything. The world is upside down when good news causes stocks to drop and a patient advocate can’t say what’s on his mind."
Should be quite a bit higher for next reporting.
Everything is possible, but maybe not likely.
If they have the proof and these institutions did something criminal, I sure hope NWBO does not settle. A settlement won't happen until well into next year and hopefully at that time we are well funded for the future. If that is the case, I want them to take it as far as it takes to get DOJ involved as I would want to see people go jo jail for the crimes they have committed and not just pay a settlement to NWBO and fees to govt.
Not sure how they have uncovered the data they have as the underlying case for their spoofing claim. Could it be that they already have a whistleblower? Or do they have forensic data experts who have discovered this data from readily available sources?
Not sure why people keep bringing these falsities up, like there is something underhanded going on between NWBO and the FDA.
You are so far off base. Maybe you and HL should take a few law classes together. The reason they have not YET included HF's and other potentially guilty third parties is because they need the evidence, which they will get through the discovery process of the current law suit.
They do need the discovery to get their hands on the good stuff, so I doubt we will see any actual suits filed until they get a bit into the discovery process. JMHO
They paint the tape at the end, because they know a lot of people are worried. There's many investors out there, like JD, Scotty etc who are only caught up in the SP at this exact moment and by shelling out a few shares at the end of the day, they can get them to post negative sentiments all weekend long.
From an attorney perspective, I think that we will see further lawsuits once the discovery process is under way. At this time, it is only the MM's targeted, but if/when they find out who the clients are, if they are acting on behalf of clients, I think we will see either a separate suit or them bringing in additional parties to this suit. It will be at this time we will see if there's been a collusion (which we all know that there has been) between third party entities like AF and Stat and the HF's and the MM's. Let's just be patient and see what they uncover. I agree that settlement at this time is not going to happen.
It's not that I think the numbers reflect reality as they use a very simple algorithm, but otcshortreport.com has not listed the daily numbers all this week. They said (saw an email from them on Twitter, I think) that it would be fixed today and that it was because they had some problems with the submission of the data from the sources (MM's I would guess). So far it has not been fixed. I highly doubt the numbers would really tell us much, just interesting that this week during the bear raid we have not been able to see them.
One positive in this short dominated SP downturn is that a non equity partnership for an indication or several indications with an upfront payment and milestone payments along the way to commercialization and a profit sharing post-commercialization is completely independent on the current SP, and solely dependent on potential revenue for the partnership in the indications. I still think that something along these lines is still a possibility. If that is the case, I think they are waiting for the MIA and possibly the Flaskworks patent. They do need to have confirmation that NWBO can produce the goods. This set-up also is beneficial for the partner as their initial cost is limited and the total cost will only be paid after they are certain of the financial benefit to them.
Lots of 1 Marshmallow kids on this board. LOL
I would think that the webinar is considered educational. As such it is like NYAS presentation. The fact that a third party charity was the host, I don't think it runs afoul any Merck, NWBO or journal embargo. Now publishing it on Youtube might, whereas I think Al could host it on his site, but not totally sure about that.
DON'T SELL SHARES TO OTCN. I am buying at 0.001 cents above their bid today as long as I have funds. Join me. I bought 10k at 0.9071. CDEL is there and their software is faster/better than OTCN, so they are buying the shares. Probably turning around and lending the shares to the shorts.....
First, we don't know if the manipulation that was previously used (Spoofing) has stopped. From my viewpoint having spent some time analyzing the daily trades, it looks like what we have seen since Dec. 1, is legal (could be illegal) shorting. It is impossible to say for sure that no spoofing has been going on. It is also impossible to say whether all the shorting is legal. My opinion is that shorty has been borrowing shares from shareholders and MM's alike. They are not only selling each day, but constantly buying shares just under where they are selling. They purposefully try to keep a decent gap between the bid/ask, so they can stealthily pick up shares that are being sold below their own ask and above others bid, and do so before they hit the 'board'. That way they have added shares to keep the 'capping' at a certain level. As long as shareholders/traders and MM's keep selling shares, they will continue to partially replenish the shares they use to cap the SP at a certain level. I don't think they are able to completely replenish the shares they use, but this tactic makes it less costly to keep the price at certain levels. They only move the price down by selling on the bid, whenever the buying interest slows down at a certain level and when in intensifies, they stop and set up a cap at the new lower level.
This is just my opinion of what is happening. I have asked a couple of traders about my theory and they agree that is likely what is happening.
The shorts do not have endless shares, so the question is how much longer they can do this. If buying interest goes up again, then we should see the spikes we have seen prior to these walkdowns. Ideally we will see only trades at bid and ask, so they will not be able to buy those shares back without others being able to see that they are doing it and move above their bid price.
I agree. I have been looking daily as I have thought "any day now" for a couple of weeks.
I agree with you if you are referring to a minor equity stake, but an out right buy out has zero chance at this point. The equity could also be timed to the milestones from the milestone payments. Those would be MIA, MAA, FDA approval, combo patent approval and combo approval.
Flipper,
What is your take on the 'delay' in the MIA cert. I have a hard time thinking that this is not pointing towards the inclusion of Flaskworks. They already had the investigational license for the facility, so I would imagine under normal circumstances the time frame should have been at or below the average time frame, yet here we are 4 weeks past the average time frame.
This purchase was likely arranged some time ago (Aug-Sept-Oct) with the completion of the events where information was available at the time of the agreement, such as Journal publication and filing of lawsuit. It is not coincidental that the purchase was effective at the end of day price of the day the lawsuit was filed. I have done purchase agreements like this before as an insider. It is the difficulty of making these investments that often time prevents insiders of pulling the trigger on buys.
This is not the MM's. This is shorty working overtime.
I highly doubt that would require a share holder vote. That would mean that share holders would have influence on the sales agreement a company makes, which they do not.
The only partnership that makes sense right now with the SP at these levels is an exclusive right to some indications that was granted with an upfront payment, milestone payments and a profit sharing arrangement. There don't have to an equity part of the deal, but there could be an arrangement for future equity purchases.
This is the only thing that would make sense for NWBO, but also the only scenario that would make sense for a BP player.
I think you are 100% correct. This was a DCVax-L webinar and they likely didn’t want to have their sponsored trial included.
Do we know when that 3 months deadline is? Do we have anyone who has the experience and knows if the option for extension is easier than filing a new patent? It does look like the timing is coincidental, though I always believe that timing is almost never coincidental. This is government time, so could be a coincidence.
So in your mind, is it reasonable to assume that there's a high likelihood that the device has passed the compatibility requirements since they have paid for it which is the last step for issuance? That was what my friend and former patent attorney suggested to me. He has been retired for 20+ years and knows nothing about NWBO, so I am not taking his prediction as the ultimate truth.
Only have one post left, so sorry if I don't respond until after 9pm PST
Thanks for your reply. My line of questioning was more in the area of: Can you make changes to a patent after it has been issued? or do you have to file for a new patent? If you have to file for a new patent, would it not make sense to wait with payment/issuance until you were certain that it passed the compatibility requirements of the MHRA so you can make the necessary changes required for the device to pass the compatibility requirements.
I am a former attorney, just not in patent law. I am not saying that paying the issue fee is an indication it works, I am just wondering if they would pay it before the compatibility studies were complete. If it was included in the MIA certification, it would make sense that they waited until the 'all clear' from MHRA before paying. I don't know if they could have made whatever changes to the flaskworks device and made changes to the patent application if the MHRA would have come back with some problems from their inspection. I don't even know if you can makes changes to the device after an issuing of the patent (which is the likely implication of payment) or if you have to file a new patent for the changed device.